Shield Therapeutics PLC Holding(s) in Company (4170J)
28 June 2017 - 7:37PM
UK Regulatory
TIDMSTX TIDMSTXW
RNS Number : 4170J
Shield Therapeutics PLC
28 June 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------
1. Identity of the issuer or SHIELD THERAPEUTICS PLC
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
------------------------------------------------------ ---------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
-----------------------------------------------------------------------------------------
An acquisition or disposal of voting rights ü
------------------------------------------------------- --------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
------------------------------------------------------- --------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
------------------------------------------------------- --------------------------------
An event changing the breakdown of voting rights ü
------------------------------------------------------- --------------------------------
Other (please
specify):
----------------------------------------------------- --------------------------------
3. Full name of person(s) W. HEALTH LP
subject to the
notification obligation:
(iii)
------------------------------------------------------ ---------------------------------
4. Full name of shareholder(s) HARGREAVE HALE NOMINEES LIMITED
(if different from 3.):(iv)
------------------------------------------------------ ---------------------------------
5. Date of the transaction 28(th) JUNE 2017
and date on
which the threshold is
crossed or
reached: (v)
------------------------------------------------------ ---------------------------------
6. Date on which issuer 28(th) JUNE 2017
notified:
------------------------------------------------------ ---------------------------------
7. Threshold(s) that is/are
crossed or
reached: (vi, vii) 49% to 48%
------------------------------------------------------ ---------------------------------
8. Notified details:
----------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
----------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
-------------- ---------------------------------- ------------------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights (x)
Shares Voting rights
Rights
-------------- ---------------- ---------------- -------------- ----------------------- -------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
-------------- ------------ ------------ -------------- --------- ------------ ------------ -----------
GB00BYV81293 54,062,901 54,062,901 56,008,541 56,008,541 48.24%
---------------- ---------------- -------------- --------- ------------ ------------ -----------
B: Qualifying Financial Instruments
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion rights that rights
(xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
------------------ -------------- -------------------------------- ------------------------- ---------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights (xix,
instrument (xvii) period refers to xx)
(xviii)
---------------- -------------- -------------- ---------------- ------------------------- -----------------------
Nominal Delta
---------------- -------------- -------------- ---------------- ------------------------- ------------ ---------
Total (A+B+C)
----------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
---------------------------------------------------- ----------------------------------------------------------------
56,008,541 48.24%
---------------------------------------------------- ----------------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
------------------------------------------------------------------------------------
Shares held by Hargreave Hale Nominees Limited
Proxy Voting:
------------------------------------------------------------------------------------
10. Name of the proxy holder: N/A
------------------------------------------------------- ---------------------------
11. Number of voting rights proxy N/A
holder will cease to hold:
------------------------------------------------------- ---------------------------
12. Date on which proxy holder will N/A
cease to hold voting rights:
------------------------------------------------------- ---------------------------
13. Additional information:
------------------------------------------------------- ---------------------------
14. Contact name: Matthew Edwards (on behalf
of W. Health L.P.)
------------------------------------------------------- ---------------------------
15. Contact telephone number: 0203 620 2000
------------------------------------------------------- ---------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLFPMLTMBJTMJR
(END) Dow Jones Newswires
June 28, 2017 05:37 ET (09:37 GMT)
Shield Therapeutics (LSE:STX)
Historical Stock Chart
From Apr 2024 to May 2024
Shield Therapeutics (LSE:STX)
Historical Stock Chart
From May 2023 to May 2024